GORE® EXCLUDER® Conformable AAA Endoprosthesis Obtains CE Mark
Continually expanding clinicians’ options in the endovascular treatment of patients with aortic disease
GORE® EXCLUDER® Iliac Branch Endoprosthesis Gains Health Canada Approval
Global reach expanded for the solution that physicians trust and patients count on
Gore Global Registry for Endovascular Aortic Treatment Enrolls 3,000 Patients
Midpoint findings to be released at 2015 Vascular Annual Meeting in Chicago
GORE® EXCLUDER® Device Reaches Significant Milestone
Proven device for endovascular aneurysm repair (EVAR) reaches 250,000 patients worldwide
Gore Applauds Medicare Announcement to Reclassify Endovascular Abdominal Aneurysm Repairs
Decision comes after two-year effort to improve the alignment of payment with cost of treatment for abdominal aortic aneurysms
Gore Applauds Medicare Announcement to Reclassify Endovascular Abdominal Aneurysm Repairs
Decision comes after two-year effort to improve the alignment of payment with cost of treatment for abdominal aortic aneurysms
Gore Unveils Next Evolution for TIPS Procedures: Lasting Diameter Control
GORE® VIATORR® TIPS Endoprosthesis with Controlled Expansion builds on a legacy of proven patency
Gore Receives Health Canada Approval for GORE® VIABAHN® Endoprosthesis Innovations, Treating Peripheral Vascular Disease
Longer and Lower Profile Options Now Available in Canada to Treat More Patient Anatomies
Final Subject Enrolled in Early Feasibility Study of the GORE® EXCLUDER® Thoracoabdominal Branch Endoprosthesis
Antegrade iteration accepted into study – advancing this branched, all-in-one system
One-Year Results in Japanese Clinical Study Affirms the GORE® VIABAHN® Endoprosthesis as a Device-of-Choice for Treating Complex SFA Disease
New clinical study shows excellent patency consistent with previous study results of self-expanding stent-graft in long, complex SFA lesions